OWC Pharmaceutical Research Corp (DYAP)

Not featured in screeners

Not featured in screeners

Ticker: DYAP

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Download results Settings

ZWEBNER ASHER

CHIEF FINANCIAL OFFICER

1 sale — total 5,000 USD

Sale 28 Jun 2009

Value US$1,829,889.11 | Price 390.10 | Shares 99,926

ZWEBNER ASHER

CHIEF FINANCIAL OFFICER

1 sale — total 10,000 USD

Sale 20 Jun 2009

Value US$47,570.98 | Price 43.11 | Shares 54,470

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2009-07-09	2009-06-28	S Sale	ZWEBNER ASHER CHIEF FINANCIAL OFFICER Executive Director	99,926 -13.2% 390.10 US$1,829,889	99,926 -13.2%	390.10	US$1,829,889
2009-07-09	2009-06-20	S Sale	ZWEBNER ASHER CHIEF FINANCIAL OFFICER Executive Director	54,470 +8.0% 43.11 US$47,571	54,470 +8.0%	43.11	US$47,571

More insider trading research around OWC Pharmaceutical Research Corp